search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    Ikena Oncology, Inc.

    (NASDAQ:IKNA)

    $4.2

    $-0.23

    -5.19%

    Ikena Oncology, Inc. Chart

    IKNA Stock Price Today

    Ikena Oncology, Inc. (IKNA) stock declined over -5.19% intraday to trade at $4.20 a share on NASDAQ. The stock opened with a loss of -4.11% at $4.51 and touched an intraday high of $4.52, falling -5.19% against the last close of $4.43. The stock went to a low of $4.11 during the session.

    Stock Snapshot

    $4.43

    Prev. Close

    160.19 Million

    Market Cap

    $4.11

    Day Low

    $4.51

    Open

    36.08 Million

    Number of Shares

    $4.52

    Day High

    -

    P/E ratio

    -1.15

    EPS (TTM)

    6.43

    Cash Flow per Share

    7.87

    Free Float in %

    5.66

    Book Value

    63,126

    Volume

    Ikena Oncology, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$4.51$4.52$4.11$4.263,100
    2022-06-30$4.38$4.47$4.15$4.4370,100
    2022-06-29$4.64$4.7$4.339$4.48133,100
    2022-06-28$4.81$4.97$4.62$4.7118,400
    2022-06-27$5.2$6.5$4.84$4.891,146,800
    2022-06-24$4.11$5.37$4$5.373,455,600
    2022-06-23$3.57$4.15$3.37$4.15330,600
    2022-06-22$3.36$3.8$3.22$3.662,595,700
    2022-06-21$3.63$3.93$3.41$3.47206,300
    2022-06-17$3.48$3.64$3.41$3.61118,500

    Contact Details

    645 Summer Street
    Suite 101
    Boston, MA 02210
    United States

    Webiste:IKNA

    857 273 8343

    Company Information

    Employees-

    Beta-

    Sales or Revenue30.98 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Ikena Oncology, Inc. (IKNA) stock price?

    Ikena Oncology, Inc. (NASDAQ: IKNA) stock price is $4.2 as of the last check on Friday, July 1. During the trading session, IKNA stock reached the peak price of $4.52 while $4.11 was the lowest point it dropped to.

    icon

    IKNA's industry and sector of operation?

    The NASDAQ listed IKNA is part of Pharmaceuticals industry that operates in the broader Health Care sector. Ikena Oncology, Inc. , a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs.

    icon

    Who are the executives of IKNA?

    Mr. Francisco Oliveira
    Head of Fin. & Admin. and Acting Principal Accounting Officer
    Ms. Maude Tessier Ph.D.
    Chief Bus. Officer
    Dr. Mark Manfredi Ph.D.
    Pres. CEO & Director
    Dr. Sergio L. Santillana M.B.A., M.D., M.Sc., MSc
    Chief Medical Officer

    icon

    What is the IKNA stock price today?

    IKNA stock traded closed the last session at $4.2, which is $-0.23 or -5.19% lower than its previous close of $4.43. IKNA's current trading price is 48.41% lower than its 52-week high of $17.60 where as its distance from 52-week low of 2.83% is -76.14%.

    icon

    How many employees does IKNA have?

    Number of IKNA employees currently stands at -. IKNA operates from 645 Summer Street, Suite 101, Boston, MA 02210, United States.

    icon

    Link for IKNA official website?

    Official Webiste of $IKNA is: https://ikenaoncology.com

    icon

    How do I contact IKNA?

    IKNA could be contacted at IKNA operates from 645 Summer Street, Suite 101, Boston, MA 02210, United States, or at phone #857 273 8343 and can also be accessed through its website.

    icon

    How many shares of IKNA are traded daily?

    IKNA stock volume for the day was 63,126 shares while in the previous session number of IKNA shares traded was 63,100 . The average number of IKNA shares traded daily for last 3 months was 292.13 Thousands.

    icon

    How much did IKNA change today?

    The percentage change in IKNA stock occurred in the recent session was -5.19% while the dollar amount for the price change in IKNA stock was $-0.23.

    icon

    What price range IKNA stock been trading in?

    In the recent session, the day high for IKNA stock was $4.52 while the low for IKNA stock touched on the day was $4.11.

    icon

    What is the market cap of IKNA currently?

    The market value of IKNA currently stands at 160.19 Million with its latest stock price at $4.2 and 36.08 Million of its shares outstanding.